Scholar Rock Holding (SRRK) Prepaid Assets (2017 - 2026)
Scholar Rock Holding (SRRK) recorded quarterly Prepaid Assets of $35.3 million in Q1 2026, up 2337.24% quarter-over-quarter from $1.4 million in Q4 2025, and up 11263.34% on a YoY basis from N/an in Q1 2025.
Scholar Rock Holding (SRRK) Prepaid Assets (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Prepaid Assets history runs 10 years deep, the most recent figure standing at $35.3 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 11263.34% year-over-year to $35.3 million; the TTM figure through Mar 2026 stood at $35.3 million (up 11263.34% YoY), while the FY2025 annual figure was $1.4 million, up 171.54% from the prior year.
- Prepaid Assets was $35.3 million for Q1 2026 at Scholar Rock Holding, up from $1.4 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $35.3 million in Q1 2026 to a low of $301000.0 in Q1 2024.
- Historically, Prepaid Assets has averaged $8.7 million across 5 years, with a median of $8.3 million in 2023.
- The sharpest annual moves came in 2024 and 2026: Prepaid Assets plunged 97.47% in 2024, then jumped 11263.34% in 2026.
- A 5-year view of Prepaid Assets shows it stood at $12.7 million in 2022, then tumbled by 34.8% to $8.3 million in 2023, then sank by 93.53% to $534000.0 in 2024, then surged by 171.54% to $1.4 million in 2025, then soared by 2337.24% to $35.3 million in 2026.
- The last three Prepaid Assets figures came in at $35.3 million (Q1 2026), $1.4 million (Q4 2025), and $789000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Scholar Rock Holding | 6.03 Bn | 5.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.34 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 789,000.00 |
| Jun 30, 2025 | 1.09 Mn |
| Mar 31, 2025 | 311,000.00 |
| Dec 31, 2024 | 534,000.00 |
| Sep 30, 2024 | 739,000.00 |
| Jun 30, 2024 | 2.91 Mn |
| Mar 31, 2024 | 301,000.00 |
| Dec 31, 2023 | 8.26 Mn |
| Sep 30, 2023 | 9.83 Mn |
| Jun 30, 2023 | 11.08 Mn |
| Mar 31, 2023 | 11.87 Mn |
| Dec 31, 2022 | 12.66 Mn |
| Sep 30, 2022 | 13.96 Mn |
| Jun 30, 2022 | 18.45 Mn |
| Mar 31, 2022 | 18.38 Mn |
| Dec 31, 2021 | 12.33 Mn |
| Sep 30, 2021 | 11.72 Mn |
| Jun 30, 2021 | 8.15 Mn |